FOCUS NIGHT & DAY (LOTRAFILCON A) SOFT CONTACT LENSES

FDA Premarket Approval P000030

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the focus night and day (lotrafilcon a) soft contact lenses. The device is indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic or aphakic persons with non-diseased eyes with up to approximately 1. 50 diopters of astigmatism. The lenses may be prescribed for extended wear for 1 to 7 days between removals for cleaning and disinfection or disposal of the lens, as recommended by the eye care professional. Lenses should be replaced every month and when removed between replacement times must be cleaned and disinfected with a chemical, not heat, disinfection system before reinsertion.

DeviceFOCUS NIGHT & DAY (LOTRAFILCON A) SOFT CONTACT LENSES
Generic NameLenses, Soft Contact, Extended Wear
ApplicantAlcon Laboratories, Inc.
Date Received2000-07-18
Decision Date2001-10-12
Notice Date2001-10-19
PMAP000030
SupplementS
Product CodeLPM 
Docket Number01M-0480
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address Alcon Laboratories, Inc. 6201 South Freeway fort Worth, TX 76134-2099
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P000030Original Filing
S003 2016-06-01 30-day Notice
S002 2016-02-26 30-day Notice
S001 2016-02-16 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.